Author/Authors :
Azimi, Maryam Department of Traditional Medicine - School of Traditional Medicine - Kerman University of Medical Sciences - Herbal and Traditional Medicines Center - Kerman University of Medical Science , Zahedi, Mohammad Javad Gasteroenterology and Hepatology Research Center - Kerman University of Medical Science , Mehrabani, Mitra Herbal and Traditional Medicines Center - Kerman University of Medical Science , Tajadini, Haleh Herbal and Traditional Medicines Center - Kerman University of Medical Science - Neuroscience Research Center - Institute of Neuropharmacology - Kerman University of Medical Science , Zolala, Farzaneh Health Research Center - Institute for Futures Studies in Health - Kerman University of Medical Science , Baneshi, Mohammad Reza Health Research Center - Institute for Futures Studies in Health - Kerman University of Medical Science , Choopani, Rasool Department of Traditional Medicine - School of Traditional Medicine - Shahid Beheshti University of Medical Science, Tehran , Sharififar, Fariba Herbal and Traditional Medicines Center - Kerman University of Medical Science , Asadipur, Ali Herbal and Traditional Medicines Center - Kerman University of Medical Science , Hayatbakhsh, Mehdi Gasteroenterology and Hepatology Research Center - Kerman University of Medical Science , Ahmadi, Bijan Gasteroenterology and Hepatology Research Center - Kerman University of Medical Science
Abstract :
Background: Functional dyspepsia (FD) is common digestive diseases affecting patients’ quality of life (QOL). Recently, improving the patients’ QOL is being considered as an important therapeutic objective; several studies have shown that traditional medicine is influential for FD patients improvement. The purpose of the present research was to investigate the effectiveness Iranian traditional medicine remedies on the QOL of patients with FD. Materials and Methods: Through double-blind randomized clinical trial, our research patients were categorized into three groups followed as AT group(Apium graveolence 250 mg and Trachyspermum copticum 250 mg, twice daily), placebo (cornstarch, 500 mg, twice daily), and (omeprazole 20 mg, daily)for a duration of one month and followed up for another one month. The patients’ QOL was measured by Nepean Dyspepsia Index short-version questionnaire at the baseline, 4 and 8 weeks after treatment onset. Results: The patients QOL of AT group after 4 weeks was found to have improved significantly in comparison to those of omeprazole and placebo groups. The statistical difference between omeprazole and placebo groups was not significant. After 8 weeks, the difference between AT and placebo groups remained significant whereas the same
was not clear between AT and omeprazole. Conclusion: Regarding our results, AT remedies could prove the FD patients’ QOL more than omeprazole or placebo; therefore, it can be used as an adjuvant therapy for treatment of the disease.
Keywords :
Functional Dyspepsia , Apium Graveolence , Carum Copticom , Quality of Life